Literature DB >> 11115737

Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation.

V Raghavendra1, G Kaur, S K Kulkarni.   

Abstract

The possible antidepressant effect of physiological and pharmacological doses of melatonin was investigated in the Porsolt forced swimming-induced behavioral despair test. The duration of immobility period of BALB/c and C57BL/6J mice during a 6-min swim test was measured at noon (11:00-12:00 h), early dark (20:00-21:00 h) and at midnight (1:00-2:00 h), respectively. The circadian time cycle did not alter the duration of immobility in either strains of mice. Similarly, exogenously administered melatonin (10-1000 microg/kg congruent with 50 nM to 5 microM/mouse), a dose that could act on high affinity melatonin receptors, did not modify the duration of immobility period at any of the time intervals studied in either strains of the mice. This suggested that neither circadian variation influenced the duration of immobility period of BALB/c and C57BL/6J mice nor at physiological doses melatonin showed any anti-depressant action. Acute administration of higher doses of melatonin (2.5-10 mg/kg) failed to induce any anti-depressant activity in mice which were subjected to forced swimming test for the first time. However, daily administration of melatonin (2.5-10 mg/kg) prior to swimming test significantly reversed the increase in immobility period that was observed on chronic exposure to swimming test. This effect was comparable with the effect of GABA-benzodiazepine (BZ) receptor agonists. Similarly, like GABAergic drugs, acute administration of melatonin also showed anti-depressant activity in a mice which were exposed to chronic forced swimming test. The anti-depressant action of melatonin was sensitive to reversal by peripheral BZ receptor antagonist, PK11195. Whereas, flumazenil failed to reverse the anti-depressant action of melatonin, thereby suggesting that central BZ receptor were not involved in its action. In conclusion the study showed that at pharmacological doses melatonin has anti-depressant action in chronic forced swimming-induced despair behavior by an action involving peripheral BZ receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115737     DOI: 10.1016/s0924-977x(00)00115-2

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  17 in total

Review 1.  Forced swimming test in mice: a review of antidepressant activity.

Authors:  Benoit Petit-Demouliere; Franck Chenu; Michel Bourin
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

Review 2.  Circadian modulation of neuroplasticity by melatonin: a target in the treatment of depression.

Authors:  Marcela Valdés-Tovar; Rosa Estrada-Reyes; Héctor Solís-Chagoyán; Jesús Argueta; Ana María Dorantes-Barrón; Daniel Quero-Chávez; Ricardo Cruz-Garduño; Montserrat G Cercós; Citlali Trueta; Julián Oikawa-Sala; Margarita L Dubocovich; Gloria Benítez-King
Journal:  Br J Pharmacol       Date:  2018-04-17       Impact factor: 8.739

3.  Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models.

Authors:  Shao-wen Tian; Moshe Laudon; Li Han; Jun Gao; Fu-lian Huang; Yu-feng Yang; Hai-feng Deng
Journal:  Acta Pharmacol Sin       Date:  2010-06-28       Impact factor: 6.150

Review 4.  Mouse behavioural analysis in systems biology.

Authors:  Peter Van Meer; Jacob Raber
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

5.  Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B).

Authors:  Han-Ting Zhang; Ying Huang; Anbrin Masood; Lisa R Stolinski; Yunfeng Li; Lei Zhang; Daniel Dlaboga; S-L Catherine Jin; Marco Conti; James M O'Donnell
Journal:  Neuropsychopharmacology       Date:  2007-08-15       Impact factor: 7.853

6.  Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression.

Authors:  David H Overstreet; Joseph Hlavka; John P Feighner; Gabriela Nicolau; Jeffrey S Freed
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

7.  Effects of calcium channel blockers on antidepressant action of Alprazolam and Imipramine.

Authors:  Sm Aburawi; Ra Al-Tubuly; Ea Alghzewi; Zm Gorash
Journal:  Libyan J Med       Date:  2007-12-01       Impact factor: 1.657

8.  Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.

Authors:  Michel Bourin; Elisabeth Mocaër; Roger Porsolt
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

9.  Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in rats.

Authors:  Florence Loiseau; Claudine Le Bihan; Michel Hamon; Marie-Hélène Thiébot
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

10.  Inhibition of Connexin 26/43 and Extracellular-Regulated Kinase Protein Plays a Critical Role in Melatonin Facilitated Gap Junctional Intercellular Communication in Hydrogen Peroxide-Treated HaCaT Keratinocyte Cells.

Authors:  Hyo-Jung Lee; Hyo-Jeong Lee; Eun Jung Sohn; Eun-Ok Lee; Jin-Hyoung Kim; Min-Ho Lee; Sung-Hoon Kim
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.